Herbert Mueller-Hartmann, Head of Global Technology Development, Lonza Bioscience

Herbert received his professional education in molecular and cellular biology at Universities of Munich and Cologne working on protein design and function linked to human disease. In 2000 he moved into industry joining amaxa biosystems doing technology development fusing molecular biology and engineering sciences and help bringing amaxa’s first product line to the market, Nucleofector™ technology. In the last one and a half decade Herbert led several R&D teams in Europe and the U.S. developing technologies and products for the QC testing, biomanufacturing, and research markets, among others for high-performance cell modification, analysis and their use in biological screening.